Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 102

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Sleep disturbance associated with the menopause

Maki, Pauline M., Panay, Nick, Simon, James A.·2024·Menopause
DOI 10.1097/gme.0000000000002386
Open this paper in CoChat — free account

Abstract

Importance and objectives: Sleep disturbance is one of the most common and debilitating symptoms experienced by women during the menopause transition. However, there are currently no therapies specifically approved for sleep disturbance associated with the menopause. Here, we consider how to characterize sleep disturbance associated with the menopause and discuss its etiology, including the latest advances in our understanding of the neuronal circuits that regulate reproduction, body temperature, sleep, and mood; and reflect on its impact on women's health and well-being. We also examine the current treatment landscape and look to the future of treatment for this condition. Methods: We conducted a review of the literature and combined this with discussion with experts in the fields of sleep and menopause as well as experiences from our own clinical practices. Discussion and conclusions: Sleep disturbance associated with the menopause is characterized by frequent night-time awakenings and increased awake time after sleep onset. Its impacts are wide-ranging, negatively affecting health as well as personal and social relationships, productivity, and work performance. There is currently an unmet need for effective, safe, and well-tolerated treatments to address this important symptom, and wider recognition of the association between sleep disturbances and the menopause is needed. Sleep disturbances associated with the menopause can result from hormone changes as well as vasomotor and mood symptoms. Growing research has contributed to our knowledge of the role of hypothalamic estrogen-sensitive kisspeptin/neurokinin B/dynorphin neurons. These neurons are thought to integrate the gonadotropin-releasing hormone pathway and the pathways responsible for the homeostatic control of body temperature and the circadian regulation of sleep-wake cycles. Understanding these neurons offers the potential to create treatments that target a key cause of sleep disturbance associated with the menopause. Further research to understand their etiology and characterize the neuronal circuits responsible could benefit the development of these targeted treatment approaches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/gme.0000000000002386

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 138

  1. 1996, The demography of menopause, Maturitas, 23, 113, 10.1016/0378-5122(95)00968-X · DOI · Paper page
  2. 2018, Sleep problems during the menopausal transition: prevalence, impact, and management challenges, Nat Sci Sleep, 10, 73, 10.2147/NSS.S125807 · DOI · Paper page
  3. 2018, Sleep and sleep disorders in the menopausal transition, Sleep Med Clin, 13, 443, 10.1016/j.jsmc.2018.04.011 · DOI · Paper page
  4. 2021, Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden, Menopause, 28, 875, 10.1097/GME.0000000000001793 · DOI
  5. 2014, Sleep in midlife women: effects of menopause, vasomotor symptoms, and depressive symptoms, Menopause, 21, 1217, 10.1097/GME.0000000000000239 · DOI
  6. 2022, Menopause and sleep disorders, J Midlife Health, 13, 26
  7. 2018, The role of sleep difficulties in the vasomotor menopausal symptoms and depressed mood relationships: an international pooled analysis of eight studies in the InterLACE consortium, Psychological Medicine, 48, 2550, 10.1017/S0033291718000168 · DOI
  8. 2021, Individual and additive-effect relationships of sleep problems and severe menopausal symptoms among women in menopausal transition, Menopause, 28, 517, 10.1097/GME.0000000000001726 · DOI
  9. 2020, Effects of pharmacologic and nonpharmacologic interventions on menopause-related quality of life: a pooled analysis of individual participant data from four MsFLASH trials, Menopause, 27, 1126, 10.1097/GME.0000000000001597 · DOI
  10. 2022, Disruption of sleep continuity during the perimenopause: associations with female reproductive hormone profiles, J Clin Endocrinol Metab, 107, e4144, 10.1210/clinem/dgac447 · DOI
  11. 2019, Italian Association of Sleep Medicine (AIMS) position statement and guideline on the treatment of menopausal sleep disorders, Maturitas, 129, 30, 10.1016/j.maturitas.2019.08.006 · DOI
  12. 2021, Guideline no. 422c: menopause: mood, sleep, and cognition, J Obstet Gynaecol Can, 43, 1316, 10.1016/j.jogc.2021.08.009 · DOI
  13. 2011, Sleep during the perimenopause: a SWAN story, Obstet Gynecol Clin North Am, 38, 567, 10.1016/j.ogc.2011.06.002 · DOI
  14. 2012, A multinational study of sleep disorders during female mid-life, Maturitas, 72, 359, 10.1016/j.maturitas.2012.05.011 · DOI
  15. 2016, Nocturnal hot flashes: relationship to objective awakenings and sleep stage transitions, J Clin Sleep Med, 12, 1003, 10.5664/jcsm.5936 · DOI
  16. 2013, A gonadotropin-releasing hormone agonist model demonstrates that nocturnal hot flashes interrupt objective sleep, Sleep, 36, 1977, 10.5665/sleep.3244 · DOI
  17. 2003, Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition, Menopause, 10, 19
  18. 2016, Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries, Post Reprod Health, 22, 112, 10.1177/2053369116632439 · DOI
  19. 2020, Menopausal symptoms and associated social and environmental factors in midlife Chinese women, Clin Interv Aging, 15, 2195, 10.2147/CIA.S278976 · DOI
  20. 2017, Sleep during menopausal transition: a 6-year follow-up, Sleep, 40
  21. 2021, Sleep during menopausal transition: a 10-year follow-up, Sleep, 44, zsaa283, 10.1093/sleep/zsaa283 · DOI
  22. 2010, Self-reported sleep difficulty during the menopausal transition: results from a prospective cohort study, Menopause, 17, 1128, 10.1097/gme.0b013e3181dd55b0 · DOI
  23. 2014, A systematic review of the longitudinal relationships between subjective sleep disturbance and menopausal stage, Maturitas, 79, 401, 10.1016/j.maturitas.2014.09.011 · DOI
  24. 2019, Sleep quality and related factors in postmenopausal women, Maturitas, 123, 73, 10.1016/j.maturitas.2019.02.008 · DOI
  25. 2005, Prevalence of insomnia and its relationship to menopausal status in middle-aged Korean women, Psych Clin Neurosci, 59, 395, 10.1111/j.1440-1819.2005.01391.x · DOI
  26. 2013, Prevalence of insomnia and related factors in a large mid-aged female Colombian sample, Maturitas, 74, 346, 10.1016/j.maturitas.2013.01.009 · DOI
  27. 2020, Effects of menopause on sleep quality and sleep disorders: Canadian Longitudinal Study on Aging, Menopause, 27, 295, 10.1097/GME.0000000000001462 · DOI
  28. 2023, Global prevalence of sleep disorders during menopause: a meta-analysis, Sleep Breath, 27, 1883, 10.1007/s11325-023-02793-5 · DOI
  29. 2018, Sleep in women across the life span, Chest, 154, 196, 10.1016/j.chest.2018.04.005 · DOI · Paper page
  30. 2020, Insomnia and menopause: a narrative review on mechanisms and treatments, Climacteric, 23, 539, 10.1080/13697137.2020.1799973 · DOI
  31. 2021, The different faces of insomnia, Front Psychiatry, 12, 683943, 10.3389/fpsyt.2021.683943 · DOI
  32. 2017, Sleep-disordered breathing and the menopausal transition among participants in the Sleep in Midlife Women Study, Menopause, 24, 157, 10.1097/GME.0000000000000744 · DOI
  33. 2016, Prolonged partial upper airway obstruction during sleep–an underdiagnosed phenotype of sleep-disordered breathing, Eur Clin Respir J, 3, 31806, 10.3402/ecrj.v3.31806 · DOI
  34. 2015, Sleep disordered breathing: is it different for females?, ERJ Open Res, 1, 00063
  35. 2021, Restless legs syndrome, Nat Rev Dis Primers, 7, 80, 10.1038/s41572-021-00311-z · DOI · Paper page
  36. 2005, Pathogenesis of obstructive and central sleep apnea, Am J Respir Crit Care Med, 172, 1363, 10.1164/rccm.200412-1631SO · DOI · Paper page
  37. 2021, Impact of sex on sleep disorders across the lifespan, Clin Chest Med, 42, 427, 10.1016/j.ccm.2021.04.005 · DOI
  38. 2015, Sleep disorders in postmenopausal women, J Sleep Disord Ther, 4, 212
  39. 2019, An integrated approach to diagnosing and managing sleep disorders in menopausal women, Maturitas, 128, 1, 10.1016/j.maturitas.2019.06.008 · DOI
  40. 2016, Sleep-wake regulation and its impact on working memory performance: the role of adenosine, Biology, 5, 11, 10.3390/biology5010011 · DOI
  41. 2017, Sleep, melatonin, and the menopausal transition: what are the links?, Sleep Sci, 10, 11, 10.5935/1984-0063.20170003 · DOI
  42. 1995, Core body temperature and circadian rhythm of hot flashes in menopausal women, J Clin Endocrinol Metab, 8, 2354
  43. 2012, Kisspeptins and reproduction: physiological roles and regulatory mechanisms, Physiol Rev, 92, 1235, 10.1152/physrev.00037.2010 · DOI · Paper page
  44. 2019, Endogenous circadian regulation of female reproductive hormones, J Clin Endocrinol Metab, 104, 6049, 10.1210/jc.2019-00803 · DOI
  45. 2018, Estradiol alters body temperature regulation in the female mouse, Temperature (Austin), 5, 56, 10.1080/23328940.2017.1384090 · DOI
  46. 2012, Role for kisspeptin/neurokinin B/dynorphin (KNDy) neurons in cutaneous vasodilatation and the estrogen modulation of body temperature, Proc Natl Acad Sci U S A, 109, 19846, 10.1073/pnas.1211517109 · DOI
  47. 2019, Neurokinin 3 receptor antagonism: a novel treatment for menopausal hot flushes, Neuroendocrinology, 109, 242, 10.1159/000495889 · DOI
  48. 2015, The integrated hypothalamic tachykinin-kisspeptin system as a central coordinator for reproduction, Neuroendocrinol, 156, 627
  49. 1991, Hypertrophy and increased gene expression of neurons containing neurokinin-B and substance-P messenger ribonucleic acids in the hypothalami of postmenopausal women, Endocrinology, 128, 2239, 10.1210/endo-128-5-2239 · DOI · Paper page
  50. 2017, Association of genetic variation in the tachykinin receptor 3 locus with hot flashes and night sweats in the Women's Health Initiative Study, Menopause, 24, 252, 10.1097/GME.0000000000000763 · DOI
  51. 1997, The dual nature of the tachykinin NK1 receptor, Trend Pharmacol Sci, 18, 351, 10.1016/S0165-6147(97)90663-5 · DOI
  52. 2023, It's not just about the hot flashes: menopausal hormone changes and disrupted sleep, J Clin Endocrinol Metab, 108, e25, 10.1210/clinem/dgac628 · DOI
  53. 2011, Relationships between menopausal and mood symptoms and EEG sleep measures in a multi-ethnic sample of middle-aged women: the SWAN sleep study, Sleep, 34, 1221, 10.5665/SLEEP.1244 · DOI
  54. 2018, Vasomotor and physical menopausal symptoms are associated with sleep quality, PloS One, 13, e0192934, 10.1371/journal.pone.0192934 · DOI
  55. 2021, Qualitative study: burden of menopause-associated vasomotor symptoms (VMS) and validation of PROMIS Sleep Disturbance and Sleep-Related Impairment measures for assessment of VMS impact on sleep, J Patient Rep Outcomes, 5, 37, 10.1186/s41687-021-00289-y · DOI
  56. 2010, Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study, Sleep, 33, 539, 10.1093/sleep/33.4.539 · DOI
  57. 2012, Are vasomotor symptoms associated with sleep characteristics among symptomatic midlife women? Comparisons of self-report and objective measures, Menopause, 19, 742, 10.1097/gme.0b013e3182422973 · DOI
  58. 2019, Hot flashes and awakenings among midlife women, Sleep, 42, zsz131, 10.1093/sleep/zsz131 · DOI
  59. 2014, Magnitude of the impact of hot flashes on sleep in perimenopausal women, Fertil Steril, 102, 1708, 10.1016/j.fertnstert.2014.08.016 · DOI
  60. 2016, Independent contributions of nocturnal hot flashes and sleep disturbance to depression in estrogen-deprived women, J Clin Endocrinol Metab, 101, 3847, 10.1210/jc.2016-2348 · DOI
  61. 2016, Symptom clusters among MsFLASH clinical trial participants, Menopause, 23, 158, 10.1097/GME.0000000000000516 · DOI
  62. 2017, It is not just menopause: symptom clustering in the Study of Women's Health Across the Nation, Womens Midlife Health, 3, 2, 10.1186/s40695-017-0021-y · DOI
  63. 2021, Premenstrual mood symptoms in the perimenopause, Curr Psychiatry Rep, 23, 73, 10.1007/s11920-021-01285-1 · DOI
  64. 2021, Longitudinal association between depressive symptoms and multidimensional sleep health: the SWAN Sleep Study, Ann Behav Med, 55, 641, 10.1093/abm/kaaa107 · DOI
  65. 2011, Vasomotor symptoms and menopause: findings from the study of women's health across the nation, Obstet Gynecol Clin N Am, 38, 489, 10.1016/j.ogc.2011.05.006 · DOI · Paper page
  66. 2015, Self-reported sleep in postmenopausal women, Menopause, 11, 198
  67. 2021, Investigation of the relationship between hot flashes, sweating and sleep quality in perimenopausal and postmenopausal women: the mediating effect of anxiety and depression, BMC Womens Health, 21, 293, 10.1186/s12905-021-01433-y · DOI
  68. 2019, Cognition, mood and sleep in menopausal transition: the role of menopause hormone therapy, Medicina (Kaunas), 55, 668, 10.3390/medicina55100668 · DOI
  69. 2015, Poor sleep in relation to natural menopause: a population-based 14-year follow-up of midlife women, Menopause, 22, 719, 10.1097/GME.0000000000000392 · DOI
  70. 2021, The evolving nexus of sleep and depression, Am J Psychiatry, 178, 896, 10.1176/appi.ajp.2021.21080821 · DOI
  71. 2005, Menopause related sleep disorders, J Clin Sleep Med, 1, 291, 10.5664/jcsm.26347 · DOI
  72. 2011, Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition, J Clin Endocrinol Metab, 96, E1044, 10.1210/jc.2010-2503 · DOI
  73. 2008, Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women, Sleep, 31, 979
  74. 2021, What happens after menopause? (WHAM): a prospective controlled study of depression and anxiety up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy, Gynecol Oncol, 161, 527, 10.1016/j.ygyno.2021.02.001 · DOI
  75. 1980, Interactions of oestrogens and hours of sleep on cortisol, FSH, LH, and prolactin in hypogonadal women, Maturitas, 2, 179, 10.1016/0378-5122(80)90002-X · DOI
  76. 2022, Different regimens of menopausal hormone therapy for improving sleep quality: a systematic review and meta-analysis, Menopause, 29, 627, 10.1097/GME.0000000000001945 · DOI
  77. 1985, Progesterone and the premenstrual syndrome: a double blind crossover trial, Br Med J (Clin Res Ed), 290, 1617, 10.1136/bmj.290.6482.1617 · DOI
  78. 2011, Progesterone prevents sleep disturbances and modulates GH, TSH, and melatonin secretion in postmenopausal women, J Clin Endocrinol Metab, 96, E614, 10.1210/jc.2010-2558 · DOI
  79. 2001, Sleep in menopause: differential effects of two forms of hormone replacement therapy, Menopause, 8, 10, 10.1097/00042192-200101000-00004 · DOI · Paper page
  80. 2015, Actigraphy-defined measures of sleep and movement across the menstrual cycle in midlife menstruating women: study of Women's Health Across the Nation Sleep Study, Menopause, 22, 66, 10.1097/GME.0000000000000249 · DOI
  81. 2019, Allopregnanolone and reproductive psychiatry: an overview, Int Rev Psychiatry, 31, 237, 10.1080/09540261.2018.1553775 · DOI
  82. 1997, Allopregnanolone affects sleep in a benzodiazepine-like fashion, J Pharmacol Exp Ther, 282, 1213, 10.1016/S0022-3565(24)36959-9 · DOI
  83. 2022, Allopregnanolone: regenerative therapeutic to restore neurological health, Neurobiol Stress, 21, 100502, 10.1016/j.ynstr.2022.100502 · DOI
  84. 2018, KNDy cells revisited, Endocrinology, 159, 3219, 10.1210/en.2018-00389 · DOI
  85. 2014, Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease, Physiol Rev, 94, 265, 10.1152/physrev.00031.2013 · DOI · Paper page
  86. 2014, Hypophysiotropic gonadotropin-releasing hormone projections are exposed to dense plexuses of kisspeptin, neurokinin B and substance p immunoreactive fibers in the human: a study on tissues from postmenopausal women, Neuroendocrinology, 100, 141, 10.1159/000368362 · DOI
  87. 2010, Mechanisms and modifiers of reflex induced cutaneous vasodilation and vasoconstriction in humans, J Appl Physiol, 109, 1221, 10.1152/japplphysiol.00298.2010 · DOI · Paper page
  88. 2006, Neurokinin-1 receptor desensitization attenuates cutaneous active vasodilatation in humans, J Physiol, 577, 1043
  89. 2020, NT-814, a non-hormonal dual NK1,3 receptor antagonist markedly improves sleep, mood and quality of life in post-menopausal women; results of a randomised, double-blind, placebo-controlled study (SWITCH-1), Menopause, 27, 1456
  90. 2023, Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1), Menopause, 30, 239, 10.1097/GME.0000000000002138 · DOI
  91. 2017, Wake-sleep circuitry: an overview, Curr Opin Neurobiol, 44, 186, 10.1016/j.conb.2017.03.021 · DOI · Paper page
  92. 2017, Neural circuitry of wakefulness and sleep, Neuron, 93, 747, 10.1016/j.neuron.2017.01.014 · DOI · Paper page
  93. 2017, Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine Clinical Practice Guideline, J Clin Sleep Med, 13, 307, 10.5664/jcsm.6470 · DOI · Paper page
  94. 2017, Efficacy of menopausal hormone therapy on sleep quality: systematic review and meta-analysis, Endocrine, 55, 702, 10.1007/s12020-016-1072-9 · DOI
  95. 2020, The 2020 Menopausal Hormone Therapy Guidelines, J Menopausal Med, 26, 69, 10.6118/jmm.20000 · DOI
  96. 2019, Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update, Ecancermedicalscience, 13, 909
  97. 2018, A qualitative assessment of health behaviors and experiences during menopause: a cross-sectional, observational study, Maturitas, 116, 36, 10.1016/j.maturitas.2018.07.014 · DOI
  98. 2013, Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network, Menopause, 20, 261, 10.1097/gme.0b013e31826d3108 · DOI
  99. 2012, Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial, Menopause, 19, 848, 10.1097/gme.0b013e3182476099 · DOI
  100. 2021, Pharmacologic and hormonal treatments for menopausal sleep disturbances: a network meta-analysis of 43 randomized controlled trials and 32,271 menopausal women, Sleep Med Rev, 57, 101469, 10.1016/j.smrv.2021.101469 · DOI
  101. 2015, Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause, Menopause, 22, 50, 10.1097/GME.0000000000000311 · DOI
  102. 2006, Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life, Menopause, 13, 780, 10.1097/01.gme.0000240633.46300.fa · DOI
  103. 2012, Sleep and antidepressant treatment, Curr Pharm Des, 18, 5802, 10.2174/138161212803523608 · DOI · Paper page
  104. 2012, Coping strategies for antidepressant side effects: an Internet survey, J Affect Disords, 143, 89, 10.1016/j.jad.2012.04.039 · DOI
  105. 2004, The effects of trazodone on sleep in patients treated with stimulant antidepressants, Sleep Med, 5, 15, 10.1016/j.sleep.2003.06.006 · DOI
  106. 2006, Use of antidepressants during perimenopause, Womens Health, 2, 627
  107. 2020, Antidepressants during and after menopausal transition: a systematic review and meta-analysis, Sci Rep, 10, 8026, 10.1038/s41598-020-64910-8 · DOI
  108. 2015, Starting antidepressant use: a qualitative synthesis of UK and Australian data, BMJ Open, 5, e008636, 10.1136/bmjopen-2015-008636 · DOI
  109. 2018, Antidepressants for insomnia in adults, Cochrane Database Syst Rev, 5, CD010753
  110. 2018, Treating insomnia with medications, Sleep Sci Pract, 2
  111. 2022, Effects of mindfulness-based relapse prevention on the chronic use of hypnotics in treatment-seeking women with insomnia: a randomized controlled trial, Int J Behav Med, 29, 266, 10.1007/s12529-021-10002-4 · DOI
  112. 2021, Review of allopregnanolone agonist therapy for the treatment of depressive disorders, Drug Des Devel Ther, 15, 3017, 10.2147/DDDT.S240856 · DOI
  113. 2023, Cognitive-behavioral, behavioural and mindfulness-based therapies for insomnia in menopause, Behav Sleep Med, 21, 488, 10.1080/15402002.2022.2109640 · DOI
  114. 2022, Behavioral interventions for improving sleep outcomes in menopausal women: a systematic review and meta-analysis, Menopause, 29, 1210, 10.1097/GME.0000000000002051 · DOI · Paper page
  115. 2018, Effects of pharmacologic and nonpharmacologic interventions on insomnia symptoms and self-reported sleep quality in women with hot flashes: a pooled analysis of individual participant data from four MsFLASH Trials, Sleep, 41, zsx190
  116. 2020, Expert opinions and consensus recommendations for the evaluation and management of insomnia in clinical practice: joint statements of five Italian scientific societies, Front Psychiatry, 11, 558, 10.3389/fpsyt.2020.00558 · DOI
  117. 2017, Digital cognitive behavioral therapy (dcbt) for insomnia: a state-of-the-science review, Curr Sleep Med Rep, 3, 48, 10.1007/s40675-017-0065-4 · DOI
  118. 2019, A nutraceutical approach to menopausal complaints, Medicina (Kaunas), 55, 544, 10.3390/medicina55090544 · DOI
  119. 2021, Herbal remedies and their possible effect on the GABAergic system and sleep, Nutrients, 13, 530, 10.3390/nu13020530 · DOI
  120. 2002, Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men, Neuropsychopharmacology, 27, 1041, 10.1016/S0893-133X(02)00369-X · DOI
  121. 2021, Insomnia disorder: clinical and research challenges for the 21st century, Eur J Neurol, 28, 2156, 10.1111/ene.14784 · DOI
  122. 2021, Advances in the treatment of chronic insomnia: a narrative review of new nonpharmacologic and pharmacologic therapies, Neuropsychiatr Dis Treat, 17, 2549, 10.2147/NDT.S297504 · DOI
  123. 2019, Complementary and alternative medicine for menopause, J Evid Based Integr Med, 24, 1
  124. 2009, Understanding the menopausal experiences of professional women, Menopause, 16, 73, 10.1097/gme.0b013e31817b614a · DOI
  125. 2005, Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review, Health Qual Life Outcomes, 3, 47, 10.1186/1477-7525-3-47 · DOI · Paper page
  126. 2016, Patterns of depressive disorders across 13 years and their determinants among midlife women: SWAN mental health study, J Affect Disord, 206, 31, 10.1016/j.jad.2016.07.005 · DOI
  127. 2021, Impact of sleep disturbances on employment and work productivity among midlife women in the US SWAN database: a brief report, Menopause, 28, 1176, 10.1097/GME.0000000000001834 · DOI
  128. 2022, Sleep fragmentation and estradiol suppression decrease fat oxidation in premenopausal women, J Clin Endocrinol Metab, 107, e3167, 10.1210/clinem/dgac313 · DOI
  129. 2013, Do reports of sleep disturbance relate to coronary and aortic calcification in healthy middle-aged women?: study of women's health across the nation, Sleep Med, 14, 282, 10.1016/j.sleep.2012.11.016 · DOI
  130. 2017, Sleep characteristics and carotid atherosclerosis among midlife women, Sleep, 40, zsw052
  131. 2019, Association of sleep characteristics with cardiovascular health among women and differences by race/ethnicity and menopausal status: findings from the American Heart Association Go Red for Women Strategically Focused Research Network, Sleep Health, 5, 501, 10.1016/j.sleh.2019.05.005 · DOI · Paper page
  132. 2019, Depression and menopause: an update on current knowledge and clinical management for this critical window, Med Clin North Am, 103, 651, 10.1016/j.mcna.2019.03.001 · DOI
  133. 2022, Risk of high depressive symptoms after the final menstrual period: the Study of Women's Health Across the Nation (SWAN), Menopause, 29, 805, 10.1097/GME.0000000000001988 · DOI
  134. 2010, Burden associated with chronic sleep maintenance insomnia characterized by nighttime awakenings among women with menopausal symptoms, Menopause, 17, 80, 10.1097/gme.0b013e3181b4c286 · DOI
  135. 2021, Cognitive profiles in perimenopause: hormonal and menopausal symptom correlates, Climacteric, 24, 401, 10.1080/13697137.2021.1892626 · DOI
  136. 2022, Brain fog in menopause: a health-care professional's guide for decision-making and counseling on cognition, Climacteric, 25, 570, 10.1080/13697137.2022.2122792 · DOI
  137. 2020, Sleep characteristics and white matter hyperintensities among midlife women, Sleep J, 43, 1
  138. 2020, Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial, Menopause, 27, 498, 10.1097/GME.0000000000001500 · DOI

Cited by

See all 102

Metadata

Authors
Maki, P. M., Panay, N., & Simon, J. A.
Affiliations
  • University of Illinois, Chicago, IL
  • Queen Charlotte's & Chelsea Hospital, Imperial College London, United Kingdom
  • George Washington University, IntimMedicine Specialists, Washington, DC.
Venue
Menopause
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2024-06-25
Volume
31
Issue
8
Pages
724-733
ISSN
1530-0374
DOI
10.1097/gme.0000000000002386
Cited by
102
References
10
Language
en
Licence
creativecommons.org/licenses/by-nc-nd/4.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sleep disturbance associated with the menopause. https://app.cochat.ai/papers/10.1097/gme.0000000000002386
The paper
Maki, P. M., Panay, N., & Simon, J. A. (2024). Sleep disturbance associated with the menopause. Menopause. https://doi.org/10.1097/gme.0000000000002386

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.